ZIMVIE INC. - COMMON STOCK

ZimVie Announces Compatibility Between its Vital™ Spinal Fixation System and Brainlab Spine & Trauma Navigation

12 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

ZimVie Reports Third Quarter 2023 Financial Results and Provides Update to Annual Guidance

01 Nov 2023 15:05:01 By Nasdaq GlobeNewswire

ZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C® Cervical Disc

31 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

ZimVie Announces Over 2,000 Children Have Received The Tether™ VBT

24 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

ZimVie Announces the Launch of Azure™ Multi-Platform Product Solutions

17 Oct 2023 07:30:00 By Nasdaq GlobeNewswire

ZimVie to Report Third Quarter 2023 Financial Results on November 1, 2023

11 Oct 2023 15:05:00 By Nasdaq GlobeNewswire

ZimVie Announces the Recent Launch of Biotivity™ A/C Plus Membrane

10 Oct 2023 07:30:00 By Nasdaq GlobeNewswire

ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study

26 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing

17 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

ZimVie Announces FDA Approval for New Mobi-C® Implant

10 Aug 2023 07:00:02 By Nasdaq GlobeNewswire

ZimVie Reports Second Quarter 2023 Financial Results and Provides Update to Annual Guidance

02 Aug 2023 15:05:01 By Nasdaq GlobeNewswire

ZimVie to Report Second Quarter 2023 Financial Results on August 2, 2023

12 Jul 2023 15:05:00 By Nasdaq GlobeNewswire

ZimVie to Present at the Stifel 2023 Jaws & Paws Conference

22 May 2023 15:05:00 By Nasdaq GlobeNewswire

ZimVie Reports First Quarter 2023 Financial Results and Provides Update to Annual Guidance

03 May 2023 15:05:01 By Nasdaq GlobeNewswire

ZimVie Opens State-of-the-Art Dental Science Educational and Training Institute in Palm Beach Gardens, Florida

27 Apr 2023 07:30:00 By Nasdaq GlobeNewswire

ZimVie Announces the Recent Launches of RegenerOss® CC Allograft Particulate and RegenerOss® Bone Graft Plug

13 Apr 2023 07:30:00 By Nasdaq GlobeNewswire

ZimVie to Report First Quarter 2023 Financial Results on May 3, 2023

12 Apr 2023 15:10:00 By Nasdaq GlobeNewswire

ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C®

03 Apr 2023 08:00:00 By Nasdaq GlobeNewswire

ZimVie’s Exclusive Puros® Cancellous Particulate Allograft Dental Bone Grafting Solution Excels in Landmark Comparative Study in The International Journal of Oral & Maxillofacial Implants

23 Mar 2023 07:30:00 By Nasdaq GlobeNewswire

ZimVie Announces Additional Positive Policy Decisions for Vertebral Body Tethering

15 Mar 2023 07:30:00 By Nasdaq GlobeNewswire